Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$144.77 USD
+0.32 (0.22%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $144.78 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Balance Sheet
Fiscal Year End for Johnson & Johnson falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 22,927 | 23,519 | 31,608 | 25,185 | 19,287 |
Receivables | 14,873 | 16,160 | 15,283 | 13,576 | 14,481 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 11,181 | 12,483 | 10,387 | 9,344 | 9,020 |
Other Current Assets | 4,514 | 3,132 | 3,701 | 3,132 | 2,486 |
Total Current Assets | 53,495 | 55,294 | 60,979 | 51,237 | 45,274 |
Net Property & Equipment | 19,898 | 19,803 | 18,962 | 18,766 | 17,658 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 9,279 | 9,123 | 10,223 | 8,534 | 7,819 |
Intangibles | 70,733 | 93,556 | 81,638 | 89,795 | 81,282 |
Deposits & Other Assets | 14,153 | 9,602 | 10,216 | 6,562 | 5,695 |
Total Assets | 167,558 | 187,378 | 182,018 | 174,894 | 157,728 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 3,451 | 12,771 | 3,766 | 2,631 | 1,202 |
Accounts Payable | 9,632 | 11,703 | 11,055 | 9,505 | 8,544 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 30,206 | 29,201 | 29,293 | 28,965 | 23,952 |
Income Taxes Payable | 2,993 | 2,127 | 1,112 | 1,392 | 2,266 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 46,282 | 55,802 | 45,226 | 42,493 | 35,964 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 3,193 | 6,374 | 7,487 | 7,214 | 5,958 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 25,881 | 26,888 | 29,985 | 32,635 | 26,494 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 23,428 | 21,510 | 25,297 | 29,274 | 29,841 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 98,784 | 110,574 | 107,995 | 111,616 | 98,257 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3,120 | 3,120 | 3,120 | 3,120 | 3,120 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 153,843 | 128,345 | 123,060 | 113,890 | 110,659 |
Other Equity | -12,527 | -12,967 | -13,058 | -15,242 | -15,891 |
Treasury Stock | 75,662 | 41,694 | 39,099 | 38,490 | 38,417 |
Total Shareholder's Equity | 68,774 | 76,804 | 74,023 | 63,278 | 59,471 |
Total Liabilities & Shareholder's Equity | 167,558 | 187,378 | 182,018 | 174,894 | 157,728 |
Total Common Equity | 68,774 | 76,804 | 74,023 | 63,278 | 59,471 |
Shares Outstanding | 2,407.20 | 2,613.60 | 2,632.60 | 2,632.50 | 2,631.80 |
Book Value Per Share | 28.57 | 29.39 | 28.12 | 24.04 | 22.60 |
Fiscal Year End for Johnson & Johnson falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 22,927 | 23,511 | 28,505 | 32,308 |
Receivables | NA | 14,873 | 14,798 | 16,777 | 16,350 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 11,181 | 11,198 | 12,888 | 12,809 |
Other Current Assets | NA | 4,514 | 4,196 | 2,397 | 2,921 |
Total Current Assets | NA | 53,495 | 53,703 | 60,567 | 64,388 |
Net Property & Equipment | NA | 19,898 | 18,821 | 20,576 | 20,174 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 9,279 | 9,259 | 8,779 | 8,817 |
Intangibles | NA | 70,733 | 71,145 | 91,686 | 93,023 |
Deposits & Other Assets | NA | 14,153 | 13,133 | 10,078 | 9,567 |
Total Assets | NA | 167,558 | 166,061 | 191,686 | 195,969 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 3,451 | 3,870 | 11,701 | 17,979 |
Accounts Payable | NA | 9,632 | 8,355 | 10,443 | 9,909 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 30,206 | 29,246 | 29,339 | 28,219 |
Income Taxes Payable | NA | 2,993 | 2,899 | 2,687 | 4,266 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 46,282 | 44,370 | 54,170 | 60,373 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 3,193 | 2,623 | 3,627 | 4,417 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 25,881 | 26,051 | 33,901 | 34,928 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 21,789 | 23,579 | 25,382 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 98,784 | 94,833 | 115,277 | 125,100 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 3,120 | 3,120 | 3,120 | 3,120 |
Capital Surplus | NA | 0 | 0 | 0 | 0 |
Retained Earnings | NA | 153,843 | 152,536 | 129,381 | 124,558 |
Other Equity | NA | -12,527 | -8,780 | -11,875 | -12,626 |
Treasury Stock | NA | 75,662 | 75,648 | 44,217 | 44,183 |
Total Shareholder's Equity | NA | 68,774 | 71,228 | 76,409 | 70,869 |
Total Liabilities & Shareholder's Equity | NA | 167,558 | 166,061 | 191,686 | 195,969 |
Total Common Equity | 0 | 68,774 | 71,228 | 76,409 | 70,869 |
Shares Outstanding | 2,409.70 | 2,407.20 | 2,407.20 | 2,598.90 | 2,598.70 |
Book Value Per Share | 0.00 | 28.57 | 29.59 | 29.40 | 27.27 |